Medical Psychological Center, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People's Republic of China.
Medical Psychological Institute, Central South University, Changsha, Hunan, 410011, People's Republic of China.
Sci Rep. 2021 Aug 17;11(1):16628. doi: 10.1038/s41598-021-96166-1.
This study was aimed to investigate whether BPD patients showed impaired impulse inhibition of emotional and non-emotional stimuli and to explore relevant neuroelectrophysiological mechanisms. A total of 32 BPD patients and 32 matched healthy controls were recruited. Self-reported scales were used to measure psychiatric symptoms. The event-related potentials (ERPs) were recorded when subjects were performing neutral and emotional Stop Signal Task (SST). Group differences in self-reported scores, behavioral variables and ERPs were compared. The BPD group scored significantly higher on impulsivity, severity of BPD symptoms, levels of depression and anxiety than the control group. In neutral SST, no significant group differences were detected in the amplitude and latency of ERPs components induced. In emotional SST, the P2 amplitude of negative emotion was significantly larger than that of neutral emotion in Go trials. In Stop trials, the P2 amplitude of BPD group was significantly smaller than that of control group, and the N2 amplitude of BPD group was significantly greater than that of control group. BPD patients showed impaired inhibition of emotional stimuli rather than non-emotional stimuli. The deficits of emotional impulse control mainly exhibit at the early attention, stimulus evaluation and conflict detection stages.
本研究旨在探讨边缘型人格障碍(BPD)患者是否存在情绪和非情绪刺激的冲动抑制受损,并探讨相关的神经电生理机制。共纳入 32 名 BPD 患者和 32 名匹配的健康对照者。采用自报告量表评估精神症状。当被试进行中性和情绪停止信号任务(SST)时,记录事件相关电位(ERP)。比较了两组在自报告评分、行为变量和 ERP 方面的差异。BPD 组在冲动性、BPD 症状严重程度、抑郁和焦虑水平方面的得分显著高于对照组。在中性 SST 中,ERP 成分的振幅和潜伏期在两组之间没有显著差异。在情绪 SST 中,在 Go 试验中,负性情绪的 P2 振幅明显大于中性情绪的 P2 振幅。在停止试验中,BPD 组的 P2 振幅明显小于对照组,BPD 组的 N2 振幅明显大于对照组。BPD 患者表现出对情绪刺激而非非情绪刺激的抑制受损。情绪冲动控制的缺陷主要表现在早期注意、刺激评价和冲突检测阶段。